government

CFOs are strategizing to protect their supply chains from drastic price hikes and product shortages.

Under a new executive order, prescription drug prices will be reduced 'almost immediately.' ? President Donald Trump, in a May...

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the...

Payer challenges are growing. Here's what CFOs are saying, and what they can do.

Pharmacists find themselves on the front lines of a tariff storm.

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual...

Medicaid cuts would severely damage access to healthcare, and healthcare leaders are speaking up.

A bill introduced in both the Senate and House would Improve Medicare reimbursement for rural providers using RPM technology.

Private equity is reshaping healthcare, pushing CFOs to rethink strategy, investment, and workforce priorities.

Payers are facing possible CMS funding cuts to Medicaid waiver programs and possible threats to SDOH data collection.

The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in...

Discover the three critical signals every healthcare leader and payer needs to watch ? before reform efforts possibly unravel.